ENOV ENOVIS CORPORATION

Enovis™ to Showcase New Surgical Innovations at AAHKS Annual Meeting

Enovis™ to Showcase New Surgical Innovations at AAHKS Annual Meeting

Company unveils new ARVIS® augmented reality system, the EMPOWR™ blade stem and more at upcoming conference in Texas

Wilmington, DE, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase the latest technologies from its Surgical business, including an updated ARVIS® Augmented Reality System, EMPOWR™ blade stem, and EMPOWR 3D Knee® at the American Association of Hip and Knee Surgeons annual meeting in Grapevine, Texas, November 2-5, 2023.

“Enovis is dedicated to surgeon-centric innovation that creates value for all stakeholders and ultimately improves patient outcomes,” stated Louie Vogt, President and General Manager of Enovis™ Surgical. “Cost effective and scalable enabling technologies have a bright future and we’re excited to take our ARVIS Augmented Reality System to the next level with new features that enable surgeons to quickly plan, execute and verify precise implant alignment, as well as now offering implant rotation and tissue balancing capabilities. We’re also thrilled to be launching our EMPOWR blade stem, which is designed to fit better than traditional blade stems and offers intraoperative efficiency through expanded options and streamlined instrumentation.”

Other offerings being showcased will include EMPOWR 3D Knee® which is the first and only dual pivot total knee on the market replicating natural motion.2,3 Additionally, Enovis will be hosting a symposium discussing our efficient revision offerings, EMPOWR Revision Knee and EXPRT Hip System.

AAHKS attendees can experience these products firsthand at booth #501.

References:

  1. Competitive data retrieved from competitors’ websites
  2. Meneghini, R. M., Deckard, E. R., Ishmael, M. K., & Ziemba-Davis, M. (2017). A dual-pivot pattern simulating native knee kinematics optimizes functional outcomes after total knee arthroplasty. The Journal of Arthroplasty, 32(10), 3009–3015. /10.1016/j.arth.2017.04.050
  3. Sandberg, Rory, et al. "Dual-pivot bearings improve ambulation and promote increased activity levels in Total knee arthroplasty: A match-controlled retrospective study." The Knee 26.6 (2019): 1243-1249.











About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit .

Media Contact:

Kristen Vick

Enovis

(512) 810-7899

Attachments



EN
30/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ENOVIS CORPORATION

 PRESS RELEASE

Enovis to Participate in Upcoming Investor Conferences

Enovis to Participate in Upcoming Investor Conferences Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13th at 8:30 a.m. Eastern Time.Wells Fargo Healthcare Conference on Wednesday, September 3rd at 2:15 p.m. Eastern Time.Baird 2025 Global Healthcare Conference on Wednesday, September 10th at 3:10 p.m. Eastern Time. A link to the l...

 PRESS RELEASE

Enovis Announces Second Quarter 2025 Results

Enovis Announces Second Quarter 2025 Results Continued commercial momentum with second-quarter sales growth of 7% on a reported basisSecond-quarter Reconstructive sales grew 11% year-over-year on a reported basis  Wilmington, DE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the second quarter ended July 4, 2025. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET. Second Quarter 2...

 PRESS RELEASE

Enovis to Host Second Quarter 2025 Results Conference Call on August 7...

Enovis to Host Second Quarter 2025 Results Conference Call on August 7th Wilmington, DE, July 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2025 financial results on Thursday, August 7th, 2025, at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, can be accessed from the "Investors" section of Enovis' website at . Conference C...

 PRESS RELEASE

Enovis to Participate in Upcoming Investor Conferences

Enovis to Participate in Upcoming Investor Conferences Wilmington, DE, June 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Goldman Sachs 46th Annual Global Healthcare Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Tuesday, June 10th at 2:00 p.m. Eastern Time.Citizens Medical Devices and Healthcare Services Forum: Ben Berry, Chief Financial Officer, will participate in investor meet...

 PRESS RELEASE

Enovis Announces First Quarter 2025 Results

Enovis Announces First Quarter 2025 Results Continued commercial momentum with first-quarter sales growth of 8% on a reported basis and strong adjusted EBITDA margin expansion First-quarter Reconstructive sales grew 11% year-over-year on a reported basis Appointed Damien McDonald as CEO, effective May 12th, 2025 Wilmington, DE, May 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the first quarter ended April 4, 2025. The Company will host an ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch